Buy Synacthen 0.25mg-AUS Tetracosactide

Synacthen 0.25mg-AUS (Tetracosactide) ampoules are used for diagnostic and therapeutic purposes in adrenal function testing and cortisol-related conditions. This Australian-made injectable supports short-term adrenal stimulation in clinical settings. Store between 2-8°C to maintain potency.

Strength

0.25mg/ml

Pack Size

Storage

2-8°

Manufacturer / TM Owner

ATNAHS PHARMA

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Uses / Indications

Tetracosactide, the active ingredient in Synacthen 0.25mg-AUS, is primarily used to assess adrenal gland function by stimulating cortisol production. It may also be prescribed for short-term treatment of adrenal insufficiency or during adrenal function tests. This medication mimics natural ACTH to evaluate pituitary-adrenal axis responsiveness.

Side Effects

Synacthen 0.25mg-AUS works by promoting cortisol release from the adrenal glands, which can temporarily improve adrenal function during testing. Users may experience mild injection-site reactions or transient systemic effects like flushing or dizziness. Effects are typically short-lived and tied to the diagnostic or therapeutic purpose.

Precautions & Warnings

Synacthen 0.25mg-AUS should be handled with care, stored refrigerated between 2-8°C, and protected from light. Avoid freezing or exposure to high temperatures. Patients with known allergies to tetracosactide or related compounds should use this medication cautiously. Always follow healthcare provider instructions for administration and disposal.

Avoid Interactions

Synacthen 0.25mg-AUS may interact with medications that affect adrenal function or cortisol levels, such as corticosteroids or ACTH analogs. Alcohol and certain herbal supplements could influence its effects. Patients should disclose all current medications to their healthcare provider before use. No specific food interactions are widely reported.

References

Frequently Asked Questions

It is used for adrenal function testing and short-term treatment of adrenal insufficiency by stimulating cortisol production.

Store refrigerated between 2-8°C and protect from light; do not freeze.

Administration should be performed by a healthcare professional in a clinical setting.

Mild injection-site reactions, flushing, or dizziness may occur but are usually temporary.

No, this medication requires a prescription and professional administration.

Published by GNH India Pharmaceuticals Limited

Last updated: 18 May 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.